Regulation of the Induction and Function of Cytotoxic T Lymphocytes by Natural Killer T Cell

Overview

Journal J Biomed Biotechnol

Specialty Biology

Date 2010 May 29

PMID 20508728

Citations 12

Authors

Hiroyasu Ito

Mitsuru Seishima

Affiliations

Soon will be listed here.

Abstract

Cytotoxic T lymphocytes (CTLs) play a crucial role in the infections and the antitumor immunity. Induction and activation of antigen-specific CTLs is an important strategy in immunotherapy for various diseases, and several researchers have focused on the modulation of CTL induction and function. Natural killer T (NKT) cells are an important focus area of researchers studying immunomodulatory responses to tumors and infectious diseases. CD1d-restricted NKT cells consist of type I NKT cells and type II NKT cells. alpha-galactosylceramide (alpha-GalCer)-activated type I NKT cells secrete both Th1 (e.g., IFN-gamma) and Th2 cytokines, affect the expression of costimulatory molecules in immune cells, and regulate the host immune system. Type II NKT cells, however, are stimulated by sulfatide, a self-glycolipid derived from myelin, and play an immunosuppressive role in animal model of autoimmune diseases. CTL generation, activation, and suppression are strongly affected by activated type I and type II NKT cells. Thus, the regulation of these NKT cells leads to the modification of CTL function. CTLs contribute to antimicrobial responses, antitumor immune and autoimmune responses. Understanding the role of NKT cells in the regulation of CTL generation, activation, and suppression enable the development of novel treatment strategies for these diseases.

Citing Articles

A platform of ADAPTive scaffolds: development of CDR-H3 β-hairpin mimics into covalent inhibitors of the PD1/PDL1 immune checkpoint.

Naylon S, Richaud A, Zhao G, Bui L, Dufresne C, Wu C RSC Chem Biol. 2024; .

PMID: 39552936 PMC: 11562385. DOI: 10.1039/d4cb00174e.

Harnessing natural killer cells for refractory/relapsed non-Hodgkin lymphoma: biological roles, clinical trials, and future prospective.

Bakhtiyaridovvombaygi M, Yazdanparast S, Kheyrandish S, Safdari S, Amiri Samani F, Sohani M Biomark Res. 2024; 12(1):66.

PMID: 39020411 PMC: 11253502. DOI: 10.1186/s40364-024-00610-z.

Nurses' roles in CAR-T therapy for B-cell malignancies and managing associated cytokine release syndrome.

Nwozichi C, Ogunmuyiwa A, Ojewale M Asia Pac J Oncol Nurs. 2024; 11(2):100367.

PMID: 38304228 PMC: 10831260. DOI: 10.1016/j.apjon.2023.100367.

Ethnic disparities in the immune microenvironment of triple negative breast cancer and its role in therapeutic outcomes.

Zajac K, Malla S, Babu R, Raman D, Tiwari A Cancer Rep (Hoboken). 2023; 6 Suppl 1:e1779.

PMID: 36632988 PMC: 10440847. DOI: 10.1002/cnr2.1779.

Immunogenic Properties of MVs Containing Structural Hantaviral Proteins: An Original Study.

Shkair L, Garanina E, Martynova E, Kolesnikova A, Arkhipova S, Titova A Pharmaceutics. 2022; 14(1).

PMID: 35056989 PMC: 8779827. DOI: 10.3390/pharmaceutics14010093.

References

Hong S, Wilson M, Serizawa I, Wu L, Singh N, Naidenko O . The natural killer T-cell ligand alpha-galactosylceramide prevents autoimmune diabetes in non-obese diabetic mice. Nat Med. 2001; 7(9):1052-6. DOI: 10.1038/nm0901-1052. View

Chang W, Kim J, Kim Y, Kim Y, Lee J, Azuma M . Cutting edge: Programmed death-1/programmed death ligand 1 interaction regulates the induction and maintenance of invariant NKT cell anergy. J Immunol. 2008; 181(10):6707-10. DOI: 10.4049/jimmunol.181.10.6707. View

Vinay D, Choi B, Bae J, Kim W, Gebhardt B, Kwon B . CD137-deficient mice have reduced NK/NKT cell numbers and function, are resistant to lipopolysaccharide-induced shock syndromes, and have lower IL-4 responses. J Immunol. 2004; 173(6):4218-29. DOI: 10.4049/jimmunol.173.6.4218. View

Shin T, Nakayama T, Akutsu Y, Motohashi S, Shibata Y, Harada M . Inhibition of tumor metastasis by adoptive transfer of IL-12-activated Valpha14 NKT cells. Int J Cancer. 2001; 91(4):523-8. DOI: 10.1002/1097-0215(20010215)91:4<523::aid-ijc1087>3.0.co;2-l. View

Pilones K, Kawashima N, Yang A, Babb J, Formenti S, Demaria S . Invariant natural killer T cells regulate breast cancer response to radiation and CTLA-4 blockade. Clin Cancer Res. 2009; 15(2):597-606. PMC: 2730222. DOI: 10.1158/1078-0432.CCR-08-1277. View

Fuss I, Heller F, Boirivant M, Leon F, Yoshida M, Fichtner-Feigl S . Nonclassical CD1d-restricted NK T cells that produce IL-13 characterize an atypical Th2 response in ulcerative colitis. J Clin Invest. 2004; 113(10):1490-7. PMC: 406524. DOI: 10.1172/JCI19836. View

Jahng A, Maricic I, Aguilera C, Cardell S, Halder R, Kumar V . Prevention of autoimmunity by targeting a distinct, noninvariant CD1d-reactive T cell population reactive to sulfatide. J Exp Med. 2004; 199(7):947-57. PMC: 2211873. DOI: 10.1084/jem.20031389. View

Gately M, Warrier R, Honasoge S, Carvajal D, Faherty D, Connaughton S . Administration of recombinant IL-12 to normal mice enhances cytolytic lymphocyte activity and induces production of IFN-gamma in vivo. Int Immunol. 1994; 6(1):157-67. DOI: 10.1093/intimm/6.1.157. View

Frankenberger B, Pohla H, Noessner E, Willimsky G, Papier B, Pezzutto A . Influence of CD80, interleukin-2, and interleukin-7 expression in human renal cell carcinoma on the expansion, function, and survival of tumor-specific CTLs. Clin Cancer Res. 2005; 11(5):1733-42. DOI: 10.1158/1078-0432.CCR-04-1883. View

10.

Moreno M, Molling J, von Mensdorff-Pouilly S, Verheijen R, Hooijberg E, Kramer D . IFN-gamma-producing human invariant NKT cells promote tumor-associated antigen-specific cytotoxic T cell responses. J Immunol. 2008; 181(4):2446-54. DOI: 10.4049/jimmunol.181.4.2446. View

11.

Santodomingo-Garzon T, Han J, Le T, Yang Y, Swain M . Natural killer T cells regulate the homing of chemokine CXC receptor 3-positive regulatory T cells to the liver in mice. Hepatology. 2009; 49(4):1267-76. DOI: 10.1002/hep.22761. View

12.

Biburger M, Tiegs G . Alpha-galactosylceramide-induced liver injury in mice is mediated by TNF-alpha but independent of Kupffer cells. J Immunol. 2005; 175(3):1540-50. DOI: 10.4049/jimmunol.175.3.1540. View

13.

Eberl G, Brawand P, MacDonald H . Selective bystander proliferation of memory CD4+ and CD8+ T cells upon NK T or T cell activation. J Immunol. 2000; 165(8):4305-11. DOI: 10.4049/jimmunol.165.8.4305. View

14.

Mo X, Tripp R, Sangster M, Doherty P . The cytotoxic T-lymphocyte response to Sendai virus is unimpaired in the absence of gamma interferon. J Virol. 1997; 71(3):1906-10. PMC: 191265. DOI: 10.1128/JVI.71.3.1906-1910.1997. View

15.

Terabe M, Swann J, Ambrosino E, Sinha P, Takaku S, Hayakawa Y . A nonclassical non-Valpha14Jalpha18 CD1d-restricted (type II) NKT cell is sufficient for down-regulation of tumor immunosurveillance. J Exp Med. 2005; 202(12):1627-33. PMC: 2212961. DOI: 10.1084/jem.20051381. View

16.

Ikeda H, Chamoto K, Tsuji T, Suzuki Y, Wakita D, Takeshima T . The critical role of type-1 innate and acquired immunity in tumor immunotherapy. Cancer Sci. 2004; 95(9):697-703. PMC: 11159994. DOI: 10.1111/j.1349-7006.2004.tb03248.x. View

17.

Zeng D, Lewis D, Dejbakhsh-Jones S, Lan F, Sibley R, Strober S . Bone marrow NK1.1(-) and NK1.1(+) T cells reciprocally regulate acute graft versus host disease. J Exp Med. 1999; 189(7):1073-81. PMC: 2193016. DOI: 10.1084/jem.189.7.1073. View

18.

Hayakawa Y, Takeda K, Yagita H, Van Kaer L, Saiki I, Okumura K . Differential regulation of Th1 and Th2 functions of NKT cells by CD28 and CD40 costimulatory pathways. J Immunol. 2001; 166(10):6012-8. DOI: 10.4049/jimmunol.166.10.6012. View

19.

Letterio J . Murine models define the role of TGF-beta as a master regulator of immune cell function. Cytokine Growth Factor Rev. 2000; 11(1-2):81-7. DOI: 10.1016/s1359-6101(99)00031-3. View

20.

Hermans I, Silk J, Gileadi U, Salio M, Mathew B, Ritter G . NKT cells enhance CD4+ and CD8+ T cell responses to soluble antigen in vivo through direct interaction with dendritic cells. J Immunol. 2003; 171(10):5140-7. DOI: 10.4049/jimmunol.171.10.5140. View